Point72 Hong Kong’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-56,675
Closed -$2.09M 650
2023
Q4
$2.09M Buy
+56,675
New +$2.13M 0.13% 204
2022
Q3
Sell
-3,553
Closed -$156K 2118
2022
Q2
$156K Buy
+3,553
New +$154K 0.01% 1052
2022
Q1
Sell
-1,402
Closed -$56K 2043
2021
Q4
$56K Buy
1,402
+275
+24% +$10.3K ﹤0.01% 1314
2021
Q3
$46K Sell
1,127
-638
-36% -$26.7K ﹤0.01% 1539
2021
Q2
$80K Buy
+1,765
New +$78.1K ﹤0.01% 1371
2021
Q1
Sell
-2,131
Closed -$91K 1970
2020
Q4
$91K Buy
+2,131
New +$76.6K ﹤0.01% 1086
2020
Q3
Sell
-5,083
Closed -$136K 1322
2020
Q2
$136K Buy
5,083
+3,845
+311% +$86.7K 0.02% 576
2020
Q1
$22K Sell
1,238
-1,923
-61% -$36.5K 0.01% 525
2019
Q4
$56K Buy
+3,161
New +$54.7K 0.01% 654
2018
Q4
Sell
-52
Closed -$1K 1011
2018
Q3
$1K Buy
+52
New +$911 ﹤0.01% 816
2018
Q2
Sell
-31
Closed -$1K 1005
2018
Q1
$1K Buy
+31
New +$600 ﹤0.01% 831
2017
Q1
Sell
-145
Closed -$1K 820
2016
Q4
$1K Sell
145
-6,655
-98% -$72.9K ﹤0.01% 809
2016
Q3
$82K Buy
+6,800
New +$69.5K 0.04% 387

Other funds holding HALO

Point72 Hong Kong's HALO Position: Q1 2024 in Review

Point72 Hong Kong sold out of Halozyme (HALO) in Q1 2024, closing a stake of 56,675 shares — an estimated $2.09M sold.

Point72 Hong Kong first reported a position in HALO in Q3 2016 and held it in 13 quarters. The position peaked at $2.09M in Q4 2023. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Point72 Hong Kong reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 56,675 Halozyme shares in Q1 2024, an estimated $2.09M.
  • Point72 Hong Kong first reported a position in Halozyme in Q3 2016 and held it in 13 quarters.
  • Point72 Hong Kong's Halozyme position peaked at $2.09M in Q4 2023.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Point72 Hong Kong's 13F filing for Q1 2024, filed 15 May 2024.